Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and cgp 74514a

lapatinib has been researched along with cgp 74514a in 1 studies

Compound Research Comparison

Studies
(lapatinib)		Trials
(lapatinib)		Recent Studies (post-2010)
(lapatinib)		Studies
(cgp 74514a)		Trials
(cgp 74514a)		Recent Studies (post-2010) (cgp 74514a)
1,9193051,44214011

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)cgp 74514a (IC50)
Cyclin-T1Homo sapiens (human)1.4
Epidermal growth factor receptorHomo sapiens (human)3.55
Cyclin-dependent kinase 1Homo sapiens (human)0.121
Cyclin-dependent kinase 4Homo sapiens (human)1.7865
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.1867
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)3
Cyclin-A2Homo sapiens (human)0.046
G1/S-specific cyclin-D1Homo sapiens (human)3
G1/S-specific cyclin-E1Homo sapiens (human)0.0215
Cyclin-dependent kinase 2Homo sapiens (human)0.0297
G1/S-specific cyclin-D3Homo sapiens (human)0.573
Dual specificity protein kinase CLK1Homo sapiens (human)0.148
Dual specificity protein kinase CLK2Homo sapiens (human)0.111
Cyclin-dependent kinase 7Homo sapiens (human)0.279
Cyclin-dependent kinase 9Homo sapiens (human)1.4
Cyclin-HHomo sapiens (human)0.279
CDK-activating kinase assembly factor MAT1Homo sapiens (human)0.279
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.026
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.026
Dual specificity protein kinase CLK4Homo sapiens (human)0.104

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gucký, T; Jorda, R; Kryštof, V; Malínková, V; Řezníčková, E1

Other Studies

1 other study(ies) available for lapatinib and cgp 74514a

ArticleYear
Trisubstituted purine inhibitors of PDGFRα and their antileukemic activity in the human eosinophilic cell line EOL-1.
    Bioorganic & medicinal chemistry, 2017, 12-15, Volume: 25, Issue:24

    Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Protein Kinase Inhibitors; Purines; Receptor, Platelet-Derived Growth Factor alpha; Structure-Activity Relationship; Tumor Cells, Cultured

2017